1.67
-0.415(-19.95%)
Currency In USD
Address
200 Penobscot Drive
Redwood City, CA 94063
United States of America
Phone
650 421 8100
Website
Sector
Healthcare
Industry
Biotechnology
Employees
188
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Dr. Stephen George Dilly MBBS, Ph.D. | President, Chief Executive Officer & Chairman | 1.3M | 1960 |
| Ms. Georgia L. Erbez | Chief Financial Officer | 514,844 | 1967 |
| Dr. Alison Moore Ph.D. | Chief Technology Officer & Executive Vice President | 586,190 | 1967 |
| Mr. Kevin Norrett M.B.A., M.S. | Chief Operating Officer | 726,567 | 1973 |
| Dr. Stefan Lutz Ph.D. | Senior Vice President of Research | 0 | N/A |
| Ms. Karen Frechou-Armijo | Senior Vice President & Head of Human Resources | 0 | N/A |
| Ms. Carrie McKim | Director of Investor Relations | 0 | N/A |
| Mr. John Schiffhauer | Senior Vice President of Intellectual Property | 0 | N/A |
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.